RSV Diagnostics

RSV Diagnostics


Global RSV Diagnostics Market to Reach US$1.2 Billion by 2030

The global market for RSV Diagnostics estimated at US$768.4 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. RSV Diagnostics Kits & Assays, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$686.6 Million by the end of the analysis period. Growth in the RSV Diagnostics Instruments segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$203.5 Million While China is Forecast to Grow at 11.6% CAGR

The RSV Diagnostics market in the U.S. is estimated at US$203.5 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$305.8 Million by the year 2030 trailing a CAGR of 11.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global RSV Diagnostics Market - Key Trends and Drivers Summarized

What Are RSV Diagnostics and Why Are They Critical for Public Health?
Respiratory Syncytial Virus (RSV) diagnostics involve a range of tests and procedures designed to detect the presence of RSV, a common respiratory virus that causes infections in the lungs and respiratory tract. RSV is particularly dangerous for infants, young children, the elderly, and immunocompromised individuals, leading to severe respiratory illnesses such as bronchiolitis and pneumonia. Early and accurate diagnosis is crucial for effective management and treatment, as it helps prevent the spread of the virus and enables timely intervention. RSV diagnostics include molecular tests like Polymerase Chain Reaction (PCR), antigen detection tests, and serological assays, each providing different levels of sensitivity, specificity, and turnaround times. As the awareness of RSV`s impact on vulnerable populations grows, the demand for efficient and rapid diagnostic solutions is rising in both clinical and point-of-care settings.

How Are Technological Advancements Shaping the RSV Diagnostics Market?
Technological advancements are playing a pivotal role in enhancing the accuracy, speed, and accessibility of RSV diagnostics. The development of rapid antigen tests that provide results in minutes is revolutionizing point-of-care diagnostics, making RSV testing more accessible in outpatient and emergency care settings. Advances in molecular diagnostics, particularly in real-time PCR and nucleic acid amplification tests (NAATs), are offering higher sensitivity and specificity, allowing for the detection of even low viral loads in samples. The introduction of multiplex panels that can simultaneously test for RSV and other respiratory pathogens, such as influenza and COVID-19, is improving diagnostic efficiency and enabling comprehensive respiratory illness management. Additionally, the use of digital platforms and telemedicine is facilitating remote diagnosis and consultation, enhancing patient access to care. These technological innovations are expanding the scope and effectiveness of RSV diagnostics, driving their adoption in both developed and developing regions.

What Challenges and Opportunities Exist in the RSV Diagnostics Market?
The RSV diagnostics market faces several challenges, including high costs of advanced diagnostic tests, variability in test accuracy, and the need for skilled personnel to operate complex diagnostic equipment. The high cost of molecular diagnostic tests, such as PCR, can be a barrier to widespread adoption, particularly in low-resource settings. Additionally, variations in the sensitivity and specificity of different tests can lead to false positives or negatives, affecting clinical decision-making. However, these challenges present significant opportunities for growth and innovation. The increasing awareness of RSV and its impact on public health, coupled with the rise in global respiratory illnesses, is driving demand for effective and affordable diagnostic solutions. The growing focus on early detection and preventive healthcare is further boosting market potential. Moreover, the expansion of telehealth and remote diagnostics is creating new opportunities for RSV diagnostics providers to offer innovative and accessible solutions.

What Factors Are Driving the Growth of the RSV Diagnostics Market?
The growth in the RSV Diagnostics market is driven by several factors, including the rising incidence of RSV infections, particularly among infants, the elderly, and immunocompromised populations. Technological advancements in rapid antigen tests, real-time PCR, multiplex panels, and digital diagnostics are enhancing the accuracy, speed, and accessibility of RSV diagnostics, driving their adoption. The increasing focus on early diagnosis, preventive healthcare, and the need to differentiate RSV from other respiratory illnesses, such as influenza and COVID-19, is also contributing to market growth. Additionally, the expansion of healthcare infrastructure, particularly in emerging markets, and the growing adoption of point-of-care testing in primary care settings are boosting the demand for RSV diagnostics. The emphasis on improving patient outcomes, reducing hospitalizations, and minimizing the spread of RSV is further propelling the RSV diagnostics market forward.

Select Competitors (Total 166 Featured) -
  • Abbott Molecular
  • Apollo Diagnostics
  • Becton, Dickinson and Company
  • Biomeb
  • BIOMED Labordiagnostik GmbH
  • bioMerieux SA
  • Bioperfectus Technologies
  • BioReference Laboratories, Inc.
  • Cellgen Diagnostics
  • Cepheid
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
RSV Diagnostics – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Early Detection and Diagnosis of Respiratory Syncytial Virus (RSV) Propels Market Growth
Increasing Use in Pediatric and Elderly Populations Expands Addressable Market Opportunity
Technological Advancements in Molecular and Point-of-Care Diagnostics Strengthen Market Position
Growing Focus on Preventing RSV-Related Complications Drives Adoption of Advanced Diagnostics
Surge in Demand for Rapid and Accurate RSV Testing Generates New Opportunities
Expanding Applications in Outpatient Clinics and Home Testing Throws Spotlight on Market Potential
Growth in Awareness and Screening Programs for Respiratory Infections Spurs Demand for RSV Diagnostics
Surge in Demand for RSV Testing During Flu Season and Outbreaks Expands Market Horizons
Growing Awareness of the Benefits of Early RSV Diagnosis in Reducing Hospitalizations Drives Market Adoption
Innovations in Portable and Digital Diagnostic Devices Generate New Market Opportunities
Rising Demand for RSV Diagnostics in Hospital and Ambulatory Care Settings Throws Spotlight on Market Dynamics
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for RSV Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Kits & Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Kits & Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Kits & Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Rapid Antigen Detection Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Rapid Antigen Detection Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Rapid Antigen Detection Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Other Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World RSV Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
JAPAN
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Japan 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
CHINA
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 41: China Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: China 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
EUROPE
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for RSV Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
FRANCE
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 56: France Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: France 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
GERMANY
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Germany 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Italy 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
UNITED KINGDOM
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: UK 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Spain Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Spain 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 83: Spain Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Spain Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Spain 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Russia Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Russia 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 89: Russia Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Russia Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Russia 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
ASIA-PACIFIC
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for RSV Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
AUSTRALIA
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 107: Australia Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Australia Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Australia 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 110: Australia Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Australia Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Australia 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
INDIA
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 113: India Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: India Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: India 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 116: India Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: India Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: India 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 119: South Korea Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: South Korea 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 122: South Korea Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: South Korea Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: South Korea 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Asia-Pacific Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Asia-Pacific 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
LATIN AMERICA
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 131: Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for RSV Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Latin America 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Latin America 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 137: Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Latin America 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 140: Argentina Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Argentina 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 143: Argentina Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Argentina Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Argentina 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
BRAZIL
TABLE 146: Brazil Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Brazil 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 149: Brazil Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Brazil Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Brazil 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
MEXICO
TABLE 152: Mexico Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Mexico 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 155: Mexico Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Mexico Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Mexico 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Rest of Latin America Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Rest of Latin America 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
MIDDLE EAST
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 164: Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for RSV Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Middle East 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Middle East 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 170: Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Middle East 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
IRAN
TABLE 173: Iran Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Iran Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Iran 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 176: Iran Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: Iran Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Iran 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
ISRAEL
TABLE 179: Israel Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Israel Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Israel 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 182: Israel Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: Israel Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Israel 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: Saudi Arabia Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Saudi Arabia 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 191: UAE Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: UAE Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: UAE 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 194: UAE Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: UAE Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: UAE 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: Rest of Middle East Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: Rest of Middle East 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
AFRICA
RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 203: Africa Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Africa Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Africa 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
TABLE 206: Africa Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Africa Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Africa 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings